What is the current Price Target for the Lantern Pharma Inc stock?

The average Lantern Pharma Inc target price is $20.40. This is 349.34% higher than the current stock price. The highest price target is 478.19%, the lowest is 233.70%. 4 Analysts have issued a price target Lantern Pharma Inc 2026 .

How high will the Lantern Pharma Inc stock rise?

No reliable answer can be given as to how high the Lantern Pharma Inc stock will rise. The performance of stocks, including the Lantern Pharma Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Lantern Pharma Inc stock today?

The performance of Lantern Pharma Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Lantern Pharma Inc stock fall?

The decline in Lantern Pharma Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Lantern Pharma Inc Forecast, price target & analysts

$4.41

2.97% today

Nasdaq, Sep 30, 04:38 pm CET

ISIN

US51654W1018

Symbol

LTRN

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Lantern Pharma Inc Target price 2025 - Analyst rating & recommendation

Lantern Pharma Inc Classifications & Recommendation:

Buy

88%

Hold

13%

Lantern Pharma Inc Price Target

Target Price	$20.40
Price	$4.54
Potential	349.34% register free of charge
Number of Estimates	4

	4 Analysts have issued a price target Lantern Pharma Inc 2026 . The average Lantern Pharma Inc target price is $20.40. This is 349.34% register free of charge higher than the current stock price. The highest price target is $26.25 478.19% register free of charge , the lowest is $15.15 233.70% register free of charge .
	A rating was issued by 8 analysts: 7 Analysts recommend Lantern Pharma Inc to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Lantern Pharma Inc stock has an average upside potential 2026 of 349.34% register free of charge . Most analysts recommend the Lantern Pharma Inc stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2030

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-1.93	-1.86
	31.29%	3.63%
P/E		negative

5 Analysts have issued a Lantern Pharma Inc forecast for earnings per share. The average Lantern Pharma Inc EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-1.93	31.29%
2025	$-1.86 3.63% Unlock
2026	$-1.59 14.52% Unlock
2027	$-1.89 18.87% Unlock
2028	$-2.21 16.93% Unlock
2029	$-2.32 4.98% Unlock
2030	$-2.50 7.76% Unlock

Current	-2.54	10.86%
2025	-2.45 3.40% Unlock
2026	-2.86 16.73% Unlock
2027	-2.41 15.73% Unlock
2028	-2.05 14.94% Unlock
2029	-1.96 4.39% Unlock
2030	-1.82 7.14% Unlock

Lantern Pharma Inc...

Current Lantern Pharma Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Lake Street	Locked ➜ Locked	Locked	Apr 02 2025

Analyst Rating	Date
Locked Lake Street: Locked ➜ Locked	Apr 02 2025

Discover more stocks with a high price target

Novo Nordisk 45.09%

TUI 43.37%

BioNTech SE - ADR 42.45%

Adyen 36.86%

Deutsche Telekom 34.68%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now